• A study to assess the safety of Anumigilimab in adults with sickle cell disease

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Italy The Netherlands
  • A study to evaluate the use of [68Ga]BED003 for imaging colorectal, gastric, pancreatic, breast, and ovarian cancers.

    Recruiting

    2 1 1
    Italy The Netherlands
  • A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Hungary Italy Poland Romania Spain
  • Evaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer

    Recruiting

    3 1 1 1
    France Sweden
  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Denmark Hungary +8
  • A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer’s disease

    Recruiting

    4 1
    Investigated Diseases:
    Czechia Germany Italy Poland Slovakia Spain
  • A study to evaluate the efficacy and safety of zenagamtide in people with obesity

    Recruiting

    3 1
    Belgium Bulgaria Denmark France Germany Italy +2
  • Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

    Recruiting

    4 1 1
    Spain
  • A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland France +9
  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Germany Italy Poland Spain

powered by